Citius Oncology, Inc. financial statements
Citius Oncology, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | −USD 24.76M | 10-K |
| Cash and equivalents | USD 3.92M | 10-Q |
Citius Oncology, Inc. financials on 6ix · Citius Oncology, Inc. on 6ix